Growth After Intestinal Transplant in Children

T. Ueno, T. Kato, K. Revas, Jeffrey Gaynor, M. Velasco, Gennaro Selvaggi, Gwenn E McLaughlin, E. Hernandez, R. Krame, J. Thompson, A. Tzakis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Intestinal transplantation has been more frequent in children with intestinal failure. However, the growth after intestinal transplantation has not been well documented. The demographics, transplant information, postoperative complications, heights, and weights were obtained retrospectively from medical records on 23 children who underwent intestinal transplantation. Z-scores were calculated from the STAT Growth-BP, based on Centers for Disease Control and Prevention growth chart (2000). Transplantations were performed between 1999 and 2004. Patient median age was 1.1 years (range 0.5 to 6.9 years). Twelve were boys and 11 girls. Seventeen children received multivisceral transplantations, one modified multivisceral transplantation, and five isolated intestinal transplantations. Baseline immunosuppression consisted of tacrolimus and corticosteroids. Daclizumab was used as induction agent in 18 patients; alemtuzumab, in five patients. Median pretransplant Z-scores were median -1.67 (n = 23) in weight, and median -3.36 (n = 21) in height. Pretransplant growth was significantly retarded. We analyzed significantly retarded patients with Z-score <-2.0. The change of weight Z-score from pretransplant was: 1.25 at 6 months (n = 11), 1.46 at 12 months (n = 10), and 2.21 at 24 months (n = 7). The change of height Z-score: 1.9 at 6 months (n = 16), 1.42 at 12 months (n = 13), and 1.51 at 24 months (n = 10). Z-score significantly improved (P < .002, ANOVA). Among the analyzed factors sex, age at transplant, length of stay, and rejection within 6 months, were not associated with catch-up growth. Children with retarded growth showed significant catch-up after successful intestinal transplantation.

Original languageEnglish
Pages (from-to)1702-1704
Number of pages3
JournalTransplantation Proceedings
Volume38
Issue number6
DOIs
StatePublished - Jul 1 2006

Fingerprint

Transplantation
Transplants
Growth
Weights and Measures
Growth Charts
Sex Factors
Age Factors
Tacrolimus
Centers for Disease Control and Prevention (U.S.)
Immunosuppression
Medical Records
Length of Stay
Analysis of Variance
Adrenal Cortex Hormones
Demography

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Growth After Intestinal Transplant in Children. / Ueno, T.; Kato, T.; Revas, K.; Gaynor, Jeffrey; Velasco, M.; Selvaggi, Gennaro; McLaughlin, Gwenn E; Hernandez, E.; Krame, R.; Thompson, J.; Tzakis, A.

In: Transplantation Proceedings, Vol. 38, No. 6, 01.07.2006, p. 1702-1704.

Research output: Contribution to journalArticle

Ueno, T, Kato, T, Revas, K, Gaynor, J, Velasco, M, Selvaggi, G, McLaughlin, GE, Hernandez, E, Krame, R, Thompson, J & Tzakis, A 2006, 'Growth After Intestinal Transplant in Children', Transplantation Proceedings, vol. 38, no. 6, pp. 1702-1704. https://doi.org/10.1016/j.transproceed.2006.05.025
Ueno, T. ; Kato, T. ; Revas, K. ; Gaynor, Jeffrey ; Velasco, M. ; Selvaggi, Gennaro ; McLaughlin, Gwenn E ; Hernandez, E. ; Krame, R. ; Thompson, J. ; Tzakis, A. / Growth After Intestinal Transplant in Children. In: Transplantation Proceedings. 2006 ; Vol. 38, No. 6. pp. 1702-1704.
@article{0c1b759d9ae84bcba16c634b732cd476,
title = "Growth After Intestinal Transplant in Children",
abstract = "Intestinal transplantation has been more frequent in children with intestinal failure. However, the growth after intestinal transplantation has not been well documented. The demographics, transplant information, postoperative complications, heights, and weights were obtained retrospectively from medical records on 23 children who underwent intestinal transplantation. Z-scores were calculated from the STAT Growth-BP, based on Centers for Disease Control and Prevention growth chart (2000). Transplantations were performed between 1999 and 2004. Patient median age was 1.1 years (range 0.5 to 6.9 years). Twelve were boys and 11 girls. Seventeen children received multivisceral transplantations, one modified multivisceral transplantation, and five isolated intestinal transplantations. Baseline immunosuppression consisted of tacrolimus and corticosteroids. Daclizumab was used as induction agent in 18 patients; alemtuzumab, in five patients. Median pretransplant Z-scores were median -1.67 (n = 23) in weight, and median -3.36 (n = 21) in height. Pretransplant growth was significantly retarded. We analyzed significantly retarded patients with Z-score <-2.0. The change of weight Z-score from pretransplant was: 1.25 at 6 months (n = 11), 1.46 at 12 months (n = 10), and 2.21 at 24 months (n = 7). The change of height Z-score: 1.9 at 6 months (n = 16), 1.42 at 12 months (n = 13), and 1.51 at 24 months (n = 10). Z-score significantly improved (P < .002, ANOVA). Among the analyzed factors sex, age at transplant, length of stay, and rejection within 6 months, were not associated with catch-up growth. Children with retarded growth showed significant catch-up after successful intestinal transplantation.",
author = "T. Ueno and T. Kato and K. Revas and Jeffrey Gaynor and M. Velasco and Gennaro Selvaggi and McLaughlin, {Gwenn E} and E. Hernandez and R. Krame and J. Thompson and A. Tzakis",
year = "2006",
month = "7",
day = "1",
doi = "10.1016/j.transproceed.2006.05.025",
language = "English",
volume = "38",
pages = "1702--1704",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Growth After Intestinal Transplant in Children

AU - Ueno, T.

AU - Kato, T.

AU - Revas, K.

AU - Gaynor, Jeffrey

AU - Velasco, M.

AU - Selvaggi, Gennaro

AU - McLaughlin, Gwenn E

AU - Hernandez, E.

AU - Krame, R.

AU - Thompson, J.

AU - Tzakis, A.

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Intestinal transplantation has been more frequent in children with intestinal failure. However, the growth after intestinal transplantation has not been well documented. The demographics, transplant information, postoperative complications, heights, and weights were obtained retrospectively from medical records on 23 children who underwent intestinal transplantation. Z-scores were calculated from the STAT Growth-BP, based on Centers for Disease Control and Prevention growth chart (2000). Transplantations were performed between 1999 and 2004. Patient median age was 1.1 years (range 0.5 to 6.9 years). Twelve were boys and 11 girls. Seventeen children received multivisceral transplantations, one modified multivisceral transplantation, and five isolated intestinal transplantations. Baseline immunosuppression consisted of tacrolimus and corticosteroids. Daclizumab was used as induction agent in 18 patients; alemtuzumab, in five patients. Median pretransplant Z-scores were median -1.67 (n = 23) in weight, and median -3.36 (n = 21) in height. Pretransplant growth was significantly retarded. We analyzed significantly retarded patients with Z-score <-2.0. The change of weight Z-score from pretransplant was: 1.25 at 6 months (n = 11), 1.46 at 12 months (n = 10), and 2.21 at 24 months (n = 7). The change of height Z-score: 1.9 at 6 months (n = 16), 1.42 at 12 months (n = 13), and 1.51 at 24 months (n = 10). Z-score significantly improved (P < .002, ANOVA). Among the analyzed factors sex, age at transplant, length of stay, and rejection within 6 months, were not associated with catch-up growth. Children with retarded growth showed significant catch-up after successful intestinal transplantation.

AB - Intestinal transplantation has been more frequent in children with intestinal failure. However, the growth after intestinal transplantation has not been well documented. The demographics, transplant information, postoperative complications, heights, and weights were obtained retrospectively from medical records on 23 children who underwent intestinal transplantation. Z-scores were calculated from the STAT Growth-BP, based on Centers for Disease Control and Prevention growth chart (2000). Transplantations were performed between 1999 and 2004. Patient median age was 1.1 years (range 0.5 to 6.9 years). Twelve were boys and 11 girls. Seventeen children received multivisceral transplantations, one modified multivisceral transplantation, and five isolated intestinal transplantations. Baseline immunosuppression consisted of tacrolimus and corticosteroids. Daclizumab was used as induction agent in 18 patients; alemtuzumab, in five patients. Median pretransplant Z-scores were median -1.67 (n = 23) in weight, and median -3.36 (n = 21) in height. Pretransplant growth was significantly retarded. We analyzed significantly retarded patients with Z-score <-2.0. The change of weight Z-score from pretransplant was: 1.25 at 6 months (n = 11), 1.46 at 12 months (n = 10), and 2.21 at 24 months (n = 7). The change of height Z-score: 1.9 at 6 months (n = 16), 1.42 at 12 months (n = 13), and 1.51 at 24 months (n = 10). Z-score significantly improved (P < .002, ANOVA). Among the analyzed factors sex, age at transplant, length of stay, and rejection within 6 months, were not associated with catch-up growth. Children with retarded growth showed significant catch-up after successful intestinal transplantation.

UR - http://www.scopus.com/inward/record.url?scp=33746899653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746899653&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2006.05.025

DO - 10.1016/j.transproceed.2006.05.025

M3 - Article

C2 - 16908254

AN - SCOPUS:33746899653

VL - 38

SP - 1702

EP - 1704

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 6

ER -